Literature DB >> 21898405

Mechanism of T-oligo-induced cell cycle arrest in Mia-PaCa pancreatic cancer cells.

Andrew M Rankin1, Sibaji Sarkar, Douglas V Faller.   

Abstract

DNA oligonucleotides with sequence homology to human telomeric DNA (T-oligo) induce cell cycle arrest, followed by apoptosis, senescence, or autophagy in a human cancer cell type-specific manner. T-oligo has potential as a new therapeutic strategy in oncology because of its ability to target certain types of tumor cells while sparing normal ones. In the present study, we demonstrate the T-oligo-induced S-phase cell cycle arrest in four pancreatic cancer cell lines. To further contribute to the mechanistic understanding of T-oligo, we also identify cyclin dependent kinase 2 (cdk2) as a functional mediator in the T-oligo-induced cell cycle arrest of pancreatic cancer cells. Ectopic expression of a constitutively active cdk2 mutant abrogates T-oligo-induced cell cycle arrest in these tumor cells while knockdown of cdk2 expression alone recapitulates the T-oligo effect. Finally, we demonstrate the dispensability of T-oligo-induced ATM/ATR-mediated DNA damage response-signaling pathways, which have long been considered functional in the T-oligo signaling mechanism.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21898405      PMCID: PMC3251650          DOI: 10.1002/jcp.22997

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  29 in total

Review 1.  Checking on the fork: the DNA-replication stress-response pathway.

Authors:  Alexander J Osborn; Stephen J Elledge; Lee Zou
Journal:  Trends Cell Biol       Date:  2002-11       Impact factor: 20.808

Review 2.  Animal cell cycles and their control.

Authors:  C Norbury; P Nurse
Journal:  Annu Rev Biochem       Date:  1992       Impact factor: 23.643

3.  T-oligos inhibit growth and induce apoptosis in human ovarian cancer cells.

Authors:  Sibaji Sarkar; Douglas V Faller
Journal:  Oligonucleotides       Date:  2011-01-31

4.  The E2F transcription factor is a cellular target for the RB protein.

Authors:  S P Chellappan; S Hiebert; M Mudryj; J M Horowitz; J R Nevins
Journal:  Cell       Date:  1991-06-14       Impact factor: 41.582

5.  Induction of apoptosis by telomere 3' overhang-specific DNA.

Authors:  Mark S Eller; Neelu Puri; Ina M Hadshiew; Suraj S Venna; Barbara A Gilchrest
Journal:  Exp Cell Res       Date:  2002-06-10       Impact factor: 3.905

6.  ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway.

Authors:  D S Lim; S T Kim; B Xu; R S Maser; J Lin; J H Petrini; M B Kastan
Journal:  Nature       Date:  2000-04-06       Impact factor: 49.962

7.  Telomere-based DNA damage responses: a new approach to melanoma.

Authors:  Neelu Puri; Mark S Eller; H Randolph Byers; Sarah Dykstra; John Kubera; Barbara A Gilchrest
Journal:  FASEB J       Date:  2004-09       Impact factor: 5.191

8.  Induction of a p95/Nbs1-mediated S phase checkpoint by telomere 3' overhang specific DNA.

Authors:  Mark S Eller; Guang-Zhi Li; Reza Firoozabadi; Neelu Puri; Barbara A Gilchrest
Journal:  FASEB J       Date:  2003-02       Impact factor: 5.191

9.  Evidence that exposure of the telomere 3' overhang sequence induces senescence.

Authors:  Guang-Zhi Li; Mark S Eller; Reza Firoozabadi; Barbara A Gilchrest
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-06       Impact factor: 11.205

10.  The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.

Authors:  J W Harper; G R Adami; N Wei; K Keyomarsi; S J Elledge
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

View more
  10 in total

1.  T-oligo as an anticancer agent in colorectal cancer.

Authors:  Luke Wojdyla; Neelu Puri; Amanda L Stone; Nan Sethakorn; Srijayaprakash B Uppada; Joseph T Devito; Marc Bissonnette
Journal:  Biochem Biophys Res Commun       Date:  2014-03-12       Impact factor: 3.575

2.  Non-small cell lung cancer is susceptible to induction of DNA damage responses and inhibition of angiogenesis by telomere overhang oligonucleotides.

Authors:  Neelu Puri; Ryan T Pitman; Richard E Mulnix; Terrianne Erickson; Audra N Iness; Connie Vitali; Yutong Zhao; Ravi Salgia
Journal:  Cancer Lett       Date:  2013-09-14       Impact factor: 8.679

3.  Telomere-homologous G-rich oligonucleotides sensitize human ovarian cancer cells to TRAIL-induced growth inhibition and apoptosis.

Authors:  Sibaji Sarkar; Douglas V Faller
Journal:  Nucleic Acid Ther       Date:  2013-05-02       Impact factor: 5.486

4.  Enhanced cytotoxicity from deoxyguanosine-enriched T-oligo in prostate cancer cells.

Authors:  Andrew M Rankin; Lora Forman; Sibaji Sarkar; Douglas V Faller
Journal:  Nucleic Acid Ther       Date:  2013-08-24       Impact factor: 5.486

5.  Telomere Fragment Induced Amnion Cell Senescence: A Contributor to Parturition?

Authors:  Jossimara Polettini; Faranak Behnia; Brandie D Taylor; George R Saade; Robert N Taylor; Ramkumar Menon
Journal:  PLoS One       Date:  2015-09-23       Impact factor: 3.240

6.  Mechanism of DNA damage responses induced by exposure to an oligonucleotide homologous to the telomere overhang in melanoma.

Authors:  Ryan T Pitman; Luke Wojdyla; Neelu Puri
Journal:  Oncotarget       Date:  2013-05

7.  Novel delivery system for T-oligo using a nanocomplex formed with an alpha helical peptide for melanoma therapy.

Authors:  Srijayaprakash B Uppada; Terrianne Erickson; Luke Wojdyla; David N Moravec; Ziyuan Song; Jianjun Cheng; Neelu Puri
Journal:  Int J Nanomedicine       Date:  2013-12-17

8.  hnRNP C1/C2 and Pur-beta proteins mediate induction of senescence by oligonucleotides homologous to the telomere overhang.

Authors:  Richard E Mulnix; Ryan T Pitman; Allison Retzer; Ceyda Bertram; Kavin Arasi; Zachary Crees; Jennifer Girard; Srijayaprakash B Uppada; Amanda L Stone; Neelu Puri
Journal:  Onco Targets Ther       Date:  2013-12-18       Impact factor: 4.147

9.  Site specific replacements of a single loop nucleoside with a dibenzyl linker may switch the activity of TBA from anticoagulant to antiproliferative.

Authors:  Maria Scuotto; Elisa Rivieccio; Alessia Varone; Daniela Corda; Mariarosaria Bucci; Valentina Vellecco; Giuseppe Cirino; Antonella Virgilio; Veronica Esposito; Aldo Galeone; Nicola Borbone; Michela Varra; Luciano Mayol
Journal:  Nucleic Acids Res       Date:  2015-08-06       Impact factor: 16.971

Review 10.  Oligonucleotides Targeting Telomeres and Telomerase in Cancer.

Authors:  Zachary Schrank; Nabiha Khan; Chike Osude; Sanjana Singh; Rachel J Miller; Collin Merrick; Alexander Mabel; Adijan Kuckovic; Neelu Puri
Journal:  Molecules       Date:  2018-09-05       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.